statistiche ricercatore

Continente	#
NA - Nord America	1.943
EU - Europa	1.037
AS - Asia	597
SA - Sud America	94
Continente sconosciuto - Info sul continente non disponibili	29
AF - Africa	22
OC - Oceania	2
Totale	3.724

Nazione	#
US - Stati Uniti d'America	1.901
PL - Polonia	315
GB - Regno Unito	209
SG - Singapore	193
IT - Italia	148
CN - Cina	126
DE - Germania	111
BR - Brasile	73
VN - Vietnam	73
SE - Svezia	71
HK - Hong Kong	51
BD - Bangladesh	46
FR - Francia	38
RU - Federazione Russa	35
UA - Ucraina	33
FI - Finlandia	31
TR - Turchia	24
CA - Canada	20
IN - India	14
ID - Indonesia	12
BE - Belgio	11
BG - Bulgaria	11
IQ - Iraq	9
UZ - Uzbekistan	8
AE - Emirati Arabi Uniti	7
AR - Argentina	7
JP - Giappone	7
MA - Marocco	6
ZA - Sudafrica	6
MX - Messico	5
CO - Colombia	4
CR - Costa Rica	4
ET - Etiopia	4
JO - Giordania	4
AL - Albania	3
AT - Austria	3
KR - Corea	3
PH - Filippine	3
VE - Venezuela	3
BZ - Belize	2
CZ - Repubblica Ceca	2
DZ - Algeria	2
EC - Ecuador	2
ES - Italia	2
GT - Guatemala	2
HN - Honduras	2
IL - Israele	2
LT - Lituania	2
MY - Malesia	2
NI - Nicaragua	2
NL - Olanda	2
NZ - Nuova Zelanda	2
PK - Pakistan	2
RO - Romania	2
SA - Arabia Saudita	2
SI - Slovenia	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
AM - Armenia	1
AO - Angola	1
AZ - Azerbaigian	1
BH - Bahrain	1
BO - Bolivia	1
CH - Svizzera	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
GH - Ghana	1
IE - Irlanda	1
IS - Islanda	1
JM - Giamaica	1
KZ - Kazakistan	1
LB - Libano	1
MD - Moldavia	1
NO - Norvegia	1
NP - Nepal	1
PA - Panama	1
PS - Palestinian Territory	1
PY - Paraguay	1
RS - Serbia	1
SC - Seychelles	1
SN - Senegal	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
Totale	3.696

Nome	#
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)	648
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals	470
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel	399
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV	383
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies	359
Modeling cost-effectiveness and health gains of a âuniversalâ versus âprioritizedâ hepatitis C virus treatment policy in a real-life cohort	333
From current status to optimization of HCV treatment: Recommendations from an expert panel	314
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019)	290
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network	270
Current and future challenges in HCV: insights from an Italian experts panel	258
Totale	3.724

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	224	0	0	0	22	7	25	18	27	25	18	51	31
2022/2023	279	44	38	30	33	27	31	9	26	19	1	11	10
2023/2024	141	5	8	11	13	14	20	14	12	6	0	13	25
2024/2025	460	13	0	6	46	86	70	26	33	74	14	30	62
2025/2026	1.173	60	26	60	88	147	374	116	32	88	66	74	42
2026/2027	190	29	57	46	58	0	0	0	0	0	0	0	0
Totale													3.724